Effects of DNAzymes targeting Aurora kinase A on the growth of human prostate cancer

Cancer Gene Therapy

Volumn 15, Issue 8, 2008, Pages 517-525

  Qu, Y ^a   Zhang, L ^b   Mao, M ^a   Zhao, F ^a   Huang, X ^c   Yang, C ^b   Xiong, Y ^a   Mu, D ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Aurora kinase A; DNAzyme; Nude mice; PC3 cell; Prostate cancer

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AURORA A KINASE; AURORA B KINASE; BETA ACTIN; CASPASE 3; DNAZYME 1; DNAZYME 2; GENE PRODUCT; MESSENGER RNA; MYC PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AURORA KINASE A GENE; BIOTECHNOLOGY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; DZ2 GENE; ENZYME DEGRADATION; ENZYME INHIBITION; FLOW CYTOMETRY; GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CLONING, MOLECULAR; DNA PRIMERS; DNA, CATALYTIC; DNA, COMPLEMENTARY; HUMANS; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES;

MUS MUSCULUS;

EID: 48249125088     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2008.22     Document Type: Article

References (31)

1. Meraldi P, Honda R, Nigg EA. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 2004; 14: 29-36.
2. Giet R, Prigent C. Aurora/Iplp-related kinases, a new oncogenic family of mitotic serine-threonine kinases. J Cell Sci 1999; 112: 3591-3601.
3. Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma XL et al. AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 2001; 159: 431-437.
4. Bar-Shira A, Pinthus JH, Rozovsky U, Goldstein M, Sellers WR, Yaron Y et al. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res 2002; 62: 6803-6807.
5. Lee EC, Frolov A, Li R, Ayala G, Greenberg NM. Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 2006; 66: 4996-5002.
6. Zhao FY, Qu Y, Zhang L, Mu DZ, Huang X, Wei DP. Effect of Aurora A on biological phenotypes of prostate cancer cells. Sichuan Da Xue Xue Bao Yi Xue Ban 2007; 38: 302-305.
7. Isaka Y. DNAzymes as potential therapeutic molecules. Curr Opin Mol Ther 2007; 9: 132-136.
8. Schubert S, Gul DC, Grunert HP, Zeichhardt H, Erdmann VA, Kurreck J. RNA cleaving '10-23' DNAzymes with enhanced stability and activity. Nucleic Acids Res 2003; 31: 5982-5992.
9. Sclhubert S, Kurreck J. Ribozyme and deoxyribozyme strategies for medical applications. Curr Drug Targets 2004; 5: 667-681.
10. Khachigian LM. DNAzymes: cutting a path to a new class of therapeutics. Curr Opin Mol Ther 2002; 4: 119-121.
11. Qu Y, Wang Z, Huang X, Wan C, Yang CL, Liu B et al. Circadian telomerase activity and DNA synthesis for timing peptide administration. Peptides 2003; 24: 363-369.
12. Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M et al. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 2003; 114: 585-598.
13. Crane R, Gadea B, Littlepage L, Wu H, Ruderman JV. Aurora A, meiosis and mitosis. Biol Cell 2004; 96: 215-229.
14. Warner SL, Bearss DJ, Han H, Von Hoff DD. Targeting Aurora-2 kinase in cancer. Mol Cancer Ther 2003; 2: 589-595.
15. Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004; 4: 927-936.
16. Dutertre S, Descamps S, Prigent C. On the role of Aurora A in centrosome function. Oncogene 2002; 21: 6175-6183.
17. Scrittori L, Hans F, Angelov D, Charra M, Prigent C, Dimitrov S. pEg2 Aurora-A kinase, histone H3 phosphorylation, and chromosome assembly in xenopus egg extract. J Biol Chem 2001; 276: 30002-30010.
18. Huang YS, Jung MY, Sarkissian M, Richter JD. N-Methyl-Daspartate recepter signaling results in Aurora kinase-catalyzed CPEB phosphorylation and CaMKII mRNA polyadenylation at synapses. EMBO J 2002; 21: 2139-2148.
19. Giet R, McLean D, Descamps S, Lee MJ, Raff JW, Prigent C et al. Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules. J Cell Biol 2002; 156: 437-451.
20. Gastro A, Mandart E, Lorca T, Galas S. Involvement of Aurora A kinase during meiosis I-II transition in Xenopus oocytes. J Biol Chem 2003; 278: 2236-2241.
21. Kufer TA, Sillje HH, Korner R, Gruss OJ, Meraldi P, Nigg EA. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002; 158: 617-623.
22. Cazales M, Schmitt E, Montembault E, Dozier C, Prigent C, Ducommun B. CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage. Cell Cycle 2005; 4: 1233-1238.
23. Yang H, Ou CC, Feldman RI, Nicosia SV, Kruk PA, Cheng JQ. Aurora A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Res 2004; 64: 463-467.
24. Saretzki G. Telomerase inhibition as cancer therapy. Cancer Lett 2003; 194: 209-219.
25. 194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening. J Biol Chem 2005; 280: 9013-9022.
26. Guan Z, Wang XR, Zhu XF, Huang XF, Xu J, Wang LH et al. Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells. Cancer Res 2007; 67: 10436-10444.
27. Kimura M, Matsuda Y, Yoshioka T, Sumi N, Okano Y. Identification and characterization of STK12/Aik2: a human gene related to Aurora of Drosophila and yeast IPL1. Cytogenet Cell Genet 1998; 82: 147-152.
28. Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 2004; 10: 262-267.
29. Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc Natl Acad Sci USA 2007; 104: 4106-4111.
30. Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N et al. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005; 65: 2899-2905.
31. Dass CR. Preclinical anticancer activity of DNA-based cleavage molecules. Drug Dev Ind Pharm 2006; 32: 1-5.